ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya University in Japan and their collaborators have developed new CAR-T cells ...

This can disrupt the cancer cell’s life cycle and may lead to cell death. The FDA granted accelerated approval to Zepzelca in June 2020 for those whose metastatic small cell lung cancer has progressed ...

However, previous studies in humans—mainly focused on prostate or colorectal cancer—have not shown a clear increase in tumor-infiltrating immune cells after exercise, even after multiple sessions.

Gene expression reveals that different types of human cell can work as a unit. These cellular modules, found in several tissues, change during disease. Gene expression reveals that different types ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...